Management ChangeMay 5, 2026, 06:02 AM
Integra LifeSciences Appoints Stuart Essig as President and CEO
AI Summary
Integra LifeSciences announced the appointment of Stuart M. Essig as President and Chief Executive Officer, effective May 1, 2026. Mr. Essig, who previously served as CEO from 1997 to 2012 and as chairman since 2012, succeeds Mojdeh Poul. The company also appointed Michael McBreen as Chief Commercial Officer, a newly created role, to strengthen revenue growth and customer focus. The Board expressed full confidence in Mr. Essig's leadership, stating this is a long-term appointment.
Key Highlights
- Stuart M. Essig appointed President and CEO, effective May 1, 2026.
- Mr. Essig will continue to serve as chairman of Integra's Board of Directors.
- He succeeds Mojdeh Poul, who is pursuing other opportunities.
- Michael McBreen appointed Chief Commercial Officer, a newly created role.
- Mr. McBreen was previously Executive Vice President, President, Codman Specialty Surgical.
- Essig previously served as Integra's CEO from 1997 through early 2012.
- The Board confirmed this is not an interim role and no CEO search will be initiated.